CARGO Therapeutics Ownership | Who Owns CARGO Therapeutics?
CARGO Therapeutics Ownership Summary
CARGO Therapeutics is owned by 113.66% institutional investors, 4.80% insiders. Fmr is the largest institutional shareholder, holding 14.61% of CRGX shares.
CRGX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CARGO Therapeutics | 113.66% | 4.80% | -18.47% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 6.96M | 14.61% | $100.39M |
| Samsara biocapital | 4.42M | 9.26% | $63.67M |
| Rtw investments, lp | 4.12M | 8.65% | $59.48M |
| Perceptive advisors | 3.68M | 7.73% | $53.11M |
| Blackrock funding, inc. /de | 2.87M | 6.03% | $41.46M |
| Janus henderson group | 2.83M | 5.94% | $40.86M |
| Nextech invest | 2.64M | 5.54% | $38.10M |
| Price t rowe associates inc /md/ | 2.44M | 5.11% | $35.13M |
| Wellington management group llp | 2.19M | 4.60% | $31.59M |
| Vanguard group | 2.08M | 4.37% | $30.06M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Yu fan | 912.00K | 24.70% | $13.15M |
| Trv gp vi | 1.87M | 23.03% | $26.92M |
| Samsara biocapital | 4.42M | 8.74% | $63.67M |
| Trv gp v | 1.74M | 8.52% | $25.05M |
| Nextech invest | 2.64M | 6.18% | $38.10M |
| Saturn v capital management | 1.01M | 5.69% | $14.53M |
| Sio capital management | 473.29K | 1.92% | $6.82M |
| Opaleye management | 750.00K | 1.89% | $10.81M |
| Perceptive advisors | 3.68M | 1.46% | $53.11M |
| Novo | 1.66M | 1.45% | $23.99M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Trv gp vi | 1.87M | 23.03% | 1.87M |
| Trv gp v | 1.74M | 8.52% | 1.74M |
| Blackrock funding, inc. /de | 2.87M | 0.00% | 327.91K |
| Sio capital management | 473.29K | 1.92% | 299.43K |
| State street | 1.08M | 0.00% | 244.65K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cowen and company | - | - | -554.30K |
| Price t rowe associates inc /md/ | 2.44M | 0.00% | -258.13K |
| Paradigm biocapital advisors lp | - | - | -147.96K |
| Tang capital management | 640.00K | 0.61% | -60.75K |
| Stempoint capital lp | - | - | -51.13K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Trv gp vi | 1.87M | 23.03% | 1.87M | $26.92M |
| Trv gp v | 1.74M | 8.52% | 1.74M | $25.05M |
| Millennium management | 96.34K | 0.00% | 96.34K | $1.39M |
| Cvi | 70.00K | 0.99% | 70.00K | $1.15M |
| Abrdn | 41.12K | 0.00% | 41.12K | $593.01K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -4.00 |
| Rothschild investment | -15.00 |
| Nisa investment advisors | -32.00 |
| Cwm | -52.00 |
| Pacer advisors | -230.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 96 | 23.08% | 54,176,403 | 15.74% | 113 | 1.18% | 62 | 16.98% | 17 | 41.67% |
| Sep 30, 2024 | 40 | -43.66% | 15,325,524 | -64.87% | 35 | 0.35% | 29 | -38.30% | 5 | -68.75% |
| Mar 31, 2024 | 65 | 47.73% | 36,387,034 | 4.03% | 88 | 1.23% | 51 | 15.91% | 6 | - |
| Dec 31, 2023 | 44 | - | 34,977,826 | - | 84 | - | 44 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 03, 2025 | Radhakrishnan Anup | See Remarks | Sell | $6.52K |
| Sep 18, 2024 | Chapman Gina | President & CEO | Sell | $179.77K |
| Sep 19, 2024 | Chapman Gina | President & CEO | Sell | $74.46K |
| Sep 18, 2024 | Radhakrishnan Anup | Chief Financial Officer | Sell | $40.45K |
| Nov 14, 2023 | PERCEPTIVE ADVISORS LLC | Former 10% Owner | Buy | $5.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | 3 |
| 2024 Q1 | - | - |
| 2023 Q4 | 2 | - |
CRGX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools